AbbVie and Cerebras Systems partner to accelerate AI research
Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption
Read More
Tag: Cerebras
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
